Perceptions of French general practitioners and patients regarding dextropropoxyphene withdrawal: a qualitative study

OBJECTIVES: Dextropropoxyphene (DXP), a step 2 analgesic commonly prescribed in France, was withdrawn from the French market in 2011 following a European decision due to its poor risk-benefit ratio. The purpose of this study was to explore the perceptions of French general practitioners (GPs) and pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Combier, Aurélie, Bon, Lucile, Van Ganse, Eric, Aubrun, Frédéric, Letrilliart, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Health Services Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157533/
https://www.ncbi.nlm.nih.gov/pubmed/30244207
http://dx.doi.org/10.1136/bmjopen-2018-021582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157533/
https://www.ncbi.nlm.nih.gov/pubmed/30244207
http://dx.doi.org/10.1136/bmjopen-2018-021582

Ejemplares similares